% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Krieg:291071,
author = {S. Krieg$^*$ and T. Rohde and T. Rausch and L. Butthof$^*$
and L. Wendler-Link$^*$ and C. Eckert$^*$ and K. Breuhahn
and B. Galy$^*$ and J. Korbel and M. Billmann and M.
Breinig$^*$ and D. F. Tschaharganeh$^*$},
title = {{M}itoferrin2 is a synthetic lethal target for chromosome
8p deleted cancers.},
journal = {Genome medicine},
volume = {16},
number = {1},
issn = {1756-994X},
address = {London},
publisher = {BioMed Central},
reportid = {DKFZ-2024-01291},
pages = {83},
year = {2024},
note = {#EA:F190#LA:F190#},
abstract = {Somatic copy number alterations are a hallmark of cancer
that offer unique opportunities for therapeutic
exploitation. Here, we focused on the identification of
specific vulnerabilities for tumors harboring chromosome 8p
deletions.We developed and applied an integrative analysis
of The Cancer Genome Atlas (TCGA), the Cancer Dependency Map
(DepMap), and the Cancer Cell Line Encyclopedia to identify
chromosome 8p-specific vulnerabilities. We employ orthogonal
gene targeting strategies, both in vitro and in vivo,
including short hairpin RNA-mediated gene knockdown and
CRISPR/Cas9-mediated gene knockout to validate
vulnerabilities.We identified SLC25A28 (also known as
MFRN2), as a specific vulnerability for tumors harboring
chromosome 8p deletions. We demonstrate that vulnerability
towards MFRN2 loss is dictated by the expression of its
paralog, SLC25A37 (also known as MFRN1), which resides on
chromosome 8p. In line with their function as mitochondrial
iron transporters, MFRN1/2 paralog protein deficiency
profoundly impaired mitochondrial respiration, induced
global depletion of iron-sulfur cluster proteins, and
resulted in DNA-damage and cell death. MFRN2 depletion in
MFRN1-deficient tumors led to impaired growth and even tumor
eradication in preclinical mouse xenograft experiments,
highlighting its therapeutic potential.Our data reveal MFRN2
as a therapeutic target of chromosome 8p deleted cancers and
nominate MFNR1 as the complimentary biomarker for
MFRN2-directed therapies.},
keywords = {Humans / Chromosomes, Human, Pair 8: genetics / Animals /
Mice / Chromosome Deletion / Neoplasms: genetics / Cell
Line, Tumor / Synthetic Lethal Mutations / Mitochondria:
metabolism / Mitochondria: genetics / Mitochondrial
Proteins: genetics / Mitochondrial Proteins: metabolism /
Gene Expression Regulation, Neoplastic / DNA Copy Number
Variations / Chromosome 8p deletion (Other) / MFRN1/2
paralog buffering (Other) / SCNAs (Other) / Synthetic
lethality (Other) / Mitochondrial Proteins (NLM Chemicals)},
cin = {F190 / D430},
ddc = {610},
cid = {I:(DE-He78)F190-20160331 / I:(DE-He78)D430-20160331},
pnm = {314 - Immunologie und Krebs (POF4-314)},
pid = {G:(DE-HGF)POF4-314},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:38886830},
doi = {10.1186/s13073-024-01357-w},
url = {https://inrepo02.dkfz.de/record/291071},
}